Royalty Pharma
RPRX
#1031
Rank
NZ$40.13 B
Marketcap
NZ$68.82
Share price
-0.43%
Change (1 day)
27.49%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: NZ$40.13 Billion

As of January 2026 Royalty Pharma has a market cap of NZ$40.13 Billion. This makes Royalty Pharma the world's 1031th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$40.13 B1.63%
2025NZ$39.49 B48.01%
2024NZ$26.68 B0.19%
2023NZ$26.63 B-3%
2022NZ$27.45 B9.57%
2021NZ$25.05 B-6.93%
2020NZ$26.92 B

End of Day market cap according to different sources

On Jan 17th, 2026 the market cap of Royalty Pharma was reported to be:

NZ$39.72 Billion
by Nasdaq info icon info icon
NZ$40.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ANI Pharmaceuticals
ANIP
NZ$3.31 B-91.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$368.75 B 818.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.619 T 3,935.98%๐Ÿ‡บ๐Ÿ‡ธ USA